[HTML][HTML] Trends, patient and prescriber characteristics in gabapentinoid use in a sample of United States ambulatory care visits from 2003 to 2016
Increasing gabapentinoid use has raised concerns of misuse and abuse in the United States
(US). Little is known about the characteristics of gabapentinoid use in general clinical …
(US). Little is known about the characteristics of gabapentinoid use in general clinical …
[HTML][HTML] Drug-induced acute angle-closure glaucoma: a review
MC Yang, KY Lin - Journal of current glaucoma practice, 2019 - ncbi.nlm.nih.gov
Aim Our goal is to review current literature regarding drug-induced acute angle-closure
glaucoma (AACG) and provide ophthalmologists and general practitioners with a thorough …
glaucoma (AACG) and provide ophthalmologists and general practitioners with a thorough …
Periferik Nöropatik Ağrı Tedavisinde Pregabalin ile Oluşan İlaç Advers Etkileri
Objective: Pregabalin is a drug used and investigated for the treatment of epilepsy,
neuropathic pain, anxiety and sleep disturbances. The aim of this study is to examine …
neuropathic pain, anxiety and sleep disturbances. The aim of this study is to examine …
A clinical overview of off-label use of gabapentinoid drugs
CW Goodman, AS Brett - JAMA internal medicine, 2019 - jamanetwork.com
Background The gabapentinoid drugs gabapentin and pregabalin were originally
developed as antiseizure drugs but now are prescribed mainly for treatment of pain. For …
developed as antiseizure drugs but now are prescribed mainly for treatment of pain. For …
[HTML][HTML] An open-label, add-on study of pregabalin in patients with partial seizures: a multicenter trial in Greece
S Tsounis, VK Kimiskidis, D Kazis, K Gkiatas… - Seizure, 2011 - Elsevier
INTRODUCTION: Pregabalin efficacy and safety as an adjunctive treatment for partial
seizures was evaluated using an open-label, flexible-dose. STUDY DESIGN: In 98 adults …
seizures was evaluated using an open-label, flexible-dose. STUDY DESIGN: In 98 adults …
Pregabalin: insights from randomized trials
BW Abou-Khalil - Epilepsy Currents, 2004 - journals.sagepub.com
PURPOSE: To evaluate pregabalin (PGB), 150 mg/day, and PGB, 600 mg/day, as an add-on
treatment for patients with refractory partial seizures concurrently treated with one to three …
treatment for patients with refractory partial seizures concurrently treated with one to three …
[HTML][HTML] Bilateral acute angle-closure glaucoma
T Matz, L Abbott - 2008 - hcplive.com
Bilateral Acute Angle-Closure Glaucoma News Media Medical World NewsPodcastsShowsState
Of Sciences - PresentationsVideosWebinars Multimedia Series CURE Connections®InsightsMedcast …
Of Sciences - PresentationsVideosWebinars Multimedia Series CURE Connections®InsightsMedcast …
A review of drug-induced acute angle closure glaucoma for non-ophthalmologists
EY Ah-Kee, E Egong, A Shafi, LT Lim, JL Yim - Qatar medical journal, 2015 - qscience.com
Acute angle closure glaucoma is an ophthalmic emergency and can lead to blindness if left
untreated. Several types of drugs have the potential to precipitate acute angle closure …
untreated. Several types of drugs have the potential to precipitate acute angle closure …
Once daily pregabalin eye drops for management of glaucoma
Elevated intraocular pressure (IOP) is the most significant risk factor contributing to visual
field loss in glaucoma. Unfortunately, the deficiencies associated with current therapies have …
field loss in glaucoma. Unfortunately, the deficiencies associated with current therapies have …
Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study
PJ Spira, RG Beran - Neurology, 2003 - AAN Enterprises
Objective: To compare efficacy and safety of gabapentin (GPT) versus placebo for
prophylaxis of chronic daily headache (CDH)(headache at least 15 days/month of greater …
prophylaxis of chronic daily headache (CDH)(headache at least 15 days/month of greater …